510(k) Report

FDA applicant

Abbott Vascular-Cardiac Therapies

Temecula, CA7 decisions2010–201220 recalls

FDA records 7 decisions for Abbott Vascular-Cardiac Therapies (Temecula, CA) from 2010 to 2012: 6 510(k) clearances and 1 original PMA approval. Most are in product codes LOX (Catheters, Transluminal Coronary Angioplasty…) and DQX (Wire, Guide, Catheter). Its devices cite 8 predicates, 1 of them its own earlier devices. 20 recalls are linked to its devices, 20 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Abbott Vascular-Cardiac Therapies’s devices, and how often a recall has named them.

FDA decisions per year

1in 2012

2010: 22011: 42012: 1
2010high 4 (2011) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

17in 2020

2017: 3, 3 Class I2020: 17, 17 Class I
2010high 17 (2020) · low 0 (2010)2026

Class I Class II/III not classified

FIG. 1 — Abbott Vascular-Cardiac Therapies by year, 2010–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Abbott Vascular-Cardiac Therapies’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Abbott”

FDA records each applicant name separately; these may or may not be the same firm.